Penumbra, Inc. (PEN)

Healthcare · Medical Devices · NYSE

Penumbra, Inc. (PEN) is a Healthcare company in the Medical Devices industry. It has a market capitalization of $12.79B, a trailing price-to-earnings ratio of 77.9 and a free-cash-flow yield of 1.4%. Over the most recent reported fiscal year, revenue grew 17.5% and free cash flow per share grew 18.7%.

Market cap	$12.79B
Trailing P/E	77.9
FCF yield	1.4%
Revenue growth (YoY)	+17.5%
EPS growth (YoY)	+33.8%
FCF/share growth (YoY)	+18.7%
Exchange	NYSE
Sector	Healthcare
Industry	Medical Devices

Explore live PEN data on Nama Insights →

Recent Congressional trades

Penumbra, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Lisa McClain	House	Sell	$1,001 - $15,000	Aug 13, 2025